Dr Reddy's Laboratories (Dr Reddy's Laboratories) Accounts Payable : $374 Mil (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Dr Reddy's Laboratories Accounts Payable?

Dr Reddy's Laboratories's Accounts Payable for the quarter that ended in Dec. 2023 was $374 Mil.

Dr Reddy's Laboratories's quarterly Accounts Payable increased from Jun. 2023 ($337 Mil) to Sep. 2023 ($367 Mil) and increased from Sep. 2023 ($367 Mil) to Dec. 2023 ($374 Mil).

Dr Reddy's Laboratories's annual Accounts Payable increased from Mar. 2021 ($174 Mil) to Mar. 2022 ($210 Mil) and increased from Mar. 2022 ($210 Mil) to Mar. 2023 ($217 Mil).

Dr Reddy's Laboratories Accounts Payable Historical Data

The historical data trend for Dr Reddy's Laboratories's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories Accounts Payable Chart

Dr Reddy's Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Accounts Payable

Get a 7-Day Free Trial

148.17

144.14

174.35

209.62

217.06

Dr Reddy's Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable	Get a 7-Day Free Trial															315.53	217.06	336.66	366.98	373.71

Dr Reddy's Laboratories Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Dr Reddy's Laboratories Accounts Payable Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Reddy's Laboratories (Dr Reddy's Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (NYSE:RDY) » Definitions » Accounts Payable

Traded in Other Exchanges

DRREDDY:India 500124:India RDDA:Germany RDDA:Germany R1DY34:Brazil

Address

8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034

Website

https://www.drreddys.com

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.